What this study adds
SLC19A1, SLCO1B1 , and SLCO1B3 polymorphisms are associated with altered activity of these transporters and affects overall survival as well as toxicity levels in lung cancer patients.
Genotyping for the SLC polymorphism could be a valuable tool for predicting which lung cancer patients will benefit the most from platinum-based doublet chemotherapy.